<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <title>PromptGenix – Research Strategy (Approach)</title>
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <style>
    * { box-sizing: border-box; }
    body {
      margin: 0;
      font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", sans-serif;
      background: #020617;
      color: #e5e7eb;
      line-height: 1.5;
    }
    a { color: inherit; text-decoration: none; }

    header {
      position: sticky;
      top: 0;
      z-index: 20;
      backdrop-filter: blur(14px);
      background: rgba(15, 23, 42, 0.92);
      border-bottom: 1px solid rgba(148, 163, 184, 0.28);
    }

    .nav {
      max-width: 1120px;
      margin: 0 auto;
      padding: 14px 20px;
      display: flex;
      align-items: center;
      justify-content: space-between;
      gap: 18px;
    }

    .nav-left { display: flex; align-items: center; gap: 12px; }
    .logo-dot {
      width: 28px; height: 28px; border-radius: 999px;
      background: radial-gradient(circle at 0 0,#38bdf8,#8b5cf6);
      box-shadow: 0 0 18px rgba(56,189,248,.7);
    }
    .brand { font-size: 1.05rem; font-weight: 650; letter-spacing: 0.04em; }
    .subbrand { font-size:.72rem;color:#9ca3af; margin-top:2px; }

    .nav-links { display:flex; gap: 12px; flex-wrap: wrap; font-size:.9rem; color:#9ca3af; }
    .nav-links a { padding: 6px 10px; border-radius: 999px; }
    .nav-links a.active, .nav-links a:hover {
      color:#e5e7eb; background: rgba(148,163,184,0.18);
    }

    main { max-width: 1120px; margin: 0 auto; padding: 34px 20px 50px; }

    .kicker {
      font-size: .78rem;
      text-transform: uppercase;
      letter-spacing: .18em;
      color: #a5b4fc;
      margin-bottom: 6px;
    }

    h1 {
      margin: 0 0 10px;
      font-size: clamp(1.9rem, 2.4vw + 1.2rem, 2.6rem);
      font-weight: 760;
      color: #f9fafb;
      letter-spacing: 0.01em;
    }

    .lede {
      max-width: 70ch;
      color: #d1d5db;
      font-size: .98rem;
      margin-bottom: 18px;
    }

    .grid {
      display: grid;
      grid-template-columns: minmax(0, 1fr) minmax(0, 1fr);
      gap: 18px;
      margin-top: 10px;
    }

    .card {
      border-radius: 16px;
      padding: 16px 18px;
      background: rgba(15,23,42,0.96);
      border: 1px solid rgba(55,65,81,0.9);
      box-shadow: 0 18px 45px rgba(15,23,42,0.65);
    }

    .card h2 {
      margin: 0 0 8px;
      font-size: 1.08rem;
      color: #e5e7eb;
    }

    .card p, .card li {
      font-size: .9rem;
      color: #d1d5db;
    }

    ul { padding-left: 1.1rem; margin: .35rem 0 0; }
    li { margin-bottom: 6px; }

    .callout {
      margin-top: 10px;
      border-radius: 14px;
      padding: 12px 14px;
      border: 1px dashed rgba(148, 163, 184, 0.5);
      background: rgba(15,23,42,0.82);
      font-size: .86rem;
      color: #e5e7eb;
    }
    .callout strong { color: #22c55e; }

    .mini {
      font-size: .82rem;
      color: #9ca3af;
      margin-top: 8px;
    }

    .row {
      display: grid;
      grid-template-columns: minmax(0, 1fr);
      gap: 18px;
      margin-top: 18px;
    }

    .pill-row { display:flex; flex-wrap:wrap; gap:8px; margin-top: 8px; }
    .pill {
      font-size: .72rem;
      padding: 5px 9px;
      border-radius: 999px;
      background: rgba(15,23,42,0.9);
      border: 1px solid rgba(129,140,248,0.45);
      color: #c7d2fe;
    }

    footer {
      max-width: 1120px;
      margin: 0 auto;
      padding: 14px 20px 22px;
      border-top: 1px solid rgba(31,41,55,0.85);
      color: #6b7280;
      font-size: .78rem;
      text-align: center;
    }

    @media (max-width: 860px) {
      .grid { grid-template-columns: minmax(0, 1fr); }
      .nav { flex-wrap: wrap; }
      .nav-links { width: 100%; justify-content: center; }
    }
  </style>
</head>
<body>

<header>
  <div class="nav">
    <div class="nav-left">
      <div class="logo-dot"></div>
      <div>
        <div class="brand">PromptGenix</div>
        <div class="subbrand">Phase I Research Strategy (Approach)</div>
      </div>
    </div>

    <nav class="nav-links">
      <a href="sbir.html">SBIR Landing</a>
      <a href="aims.html">Specific Aims</a>
      <a href="approach.html" class="active">Approach</a>
      <a href="use-cases.html">Use Cases</a>
    </nav>

    <div class="nav-links">
      <a href="mailto:dohoon.kim1@icloud.com?subject=PromptGenix%20SBIR%20Approach%20Inquiry">Email</a>
    </div>
  </div>
</header>

<main>
  <div class="kicker">Research Strategy</div>
  <h1>Approach (Phase I): Workflow, validation plan, and measurable KPIs</h1>
  <p class="lede">
    Phase I hardens PromptGenix into a reviewer-ready, reproducible BioAI automation platform using <strong>public datasets only</strong>.
    The goal is to demonstrate: (i) reliable end-to-end pipelines for RNA-Seq and flow cytometry, and (ii) a traceable
    <strong>Hypothesis Generator</strong> that produces ranked, testable hypotheses with PubMed-linked evidence.
  </p>

<!-- WORKFLOW FIGURE (SVG) -->
<section class="card" style="margin-top:14px;">
  <div class="kicker" style="margin:0 0 8px;">Phase I Workflow Figure</div>

  <svg viewBox="0 0 1120 340" width="100%" height="auto" role="img" aria-label="PromptGenix Phase I workflow from inputs to pipelines, LLM interpretation, hypothesis generator, and reports"
       style="display:block;border-radius:14px;background:rgba(2,6,23,0.35);border:1px solid rgba(55,65,81,0.75);">
    <defs>
      <linearGradient id="g1" x1="0" y1="0" x2="1" y2="1">
        <stop offset="0%" stop-color="#22d3ee" stop-opacity="0.9"/>
        <stop offset="55%" stop-color="#6366f1" stop-opacity="0.9"/>
        <stop offset="100%" stop-color="#22c55e" stop-opacity="0.9"/>
      </linearGradient>

      <filter id="softGlow" x="-40%" y="-40%" width="180%" height="180%">
        <feGaussianBlur stdDeviation="8" result="blur"/>
        <feColorMatrix in="blur" type="matrix"
          values="1 0 0 0 0
                  0 1 0 0 0
                  0 0 1 0 0
                  0 0 0 0.55 0" result="glow"/>
        <feMerge>
          <feMergeNode in="glow"/>
          <feMergeNode in="SourceGraphic"/>
        </feMerge>
      </filter>

      <marker id="arrow" markerWidth="10" markerHeight="10" refX="9" refY="3" orient="auto">
        <path d="M0,0 L10,3 L0,6 Z" fill="#94a3b8" />
      </marker>

      <style>
        .bx { fill: rgba(15,23,42,0.92); stroke: rgba(148,163,184,0.55); stroke-width: 1.2; rx: 18; ry: 18; }
        .ttl { font: 700 16px -apple-system,BlinkMacSystemFont,Segoe UI,sans-serif; fill: #f9fafb; }
        .sub { font: 500 12.5px -apple-system,BlinkMacSystemFont,Segoe UI,sans-serif; fill: #d1d5db; }
        .tag { font: 600 11px -apple-system,BlinkMacSystemFont,Segoe UI,sans-serif; fill: #c7d2fe; }
        .line { stroke: rgba(148,163,184,0.75); stroke-width: 2; fill: none; marker-end: url(#arrow); }
        .badge { fill: rgba(15,23,42,0.9); stroke: rgba(129,140,248,0.55); stroke-width: 1; rx: 999; ry: 999; }
      </style>
    </defs>

    <!-- top gradient accent -->
    <rect x="22" y="18" width="1076" height="8" rx="8" fill="url(#g1)" filter="url(#softGlow)"/>

    <!-- Column 1: Inputs -->
    <rect class="bx" x="40" y="60" width="240" height="210"/>
    <text class="ttl" x="64" y="92">Inputs</text>
    <text class="sub" x="64" y="118">• FASTQ / FCS</text>
    <text class="sub" x="64" y="140">• Public accession IDs</text>
    <text class="sub" x="64" y="162">• Minimal metadata</text>

    <rect class="badge" x="64" y="190" width="192" height="26"/>
    <text class="tag" x="80" y="208">Public-data Phase I</text>

    <!-- Column 2: Pipelines -->
    <rect class="bx" x="320" y="60" width="300" height="210"/>
    <text class="ttl" x="344" y="92">Automated Pipelines</text>
    <text class="sub" x="344" y="118">RNA-Seq: QC → align/quant → DEG → GSEA/GSVA</text>
    <text class="sub" x="344" y="142">Flow: QC → transforms → batch norm → summaries</text>
    <text class="sub" x="344" y="166">Versioned configs + reproducible outputs</text>

    <!-- Column 3: LLM + Hypothesis -->
    <rect class="bx" x="660" y="60" width="260" height="210"/>
    <text class="ttl" x="684" y="92">Evidence-aware LLM</text>
    <text class="sub" x="684" y="118">• Interprets results</text>
    <text class="sub" x="684" y="140">• PubMed-linked evidence</text>
    <text class="sub" x="684" y="162">• Structured summaries</text>

    <rect x="684" y="182" width="212" height="64" rx="14" ry="14"
          fill="rgba(15,23,42,0.9)" stroke="rgba(34,197,94,0.55)" stroke-width="1.2"/>
    <text class="ttl" x="700" y="210" style="font-size:14px;">Hypothesis Generator</text>
    <text class="sub" x="700" y="232">Ranked hypotheses + experiments</text>

    <!-- Column 4: Outputs -->
    <rect class="bx" x="960" y="60" width="120" height="210"/>
    <text class="ttl" x="976" y="92">Outputs</text>
    <text class="sub" x="976" y="118">HTML/PDF</text>
    <text class="sub" x="976" y="140">Figures</text>
    <text class="sub" x="976" y="162">Methods</text>
    <text class="sub" x="976" y="184">Citations</text>

    <!-- arrows -->
    <path class="line" d="M280 165 C300 165, 300 165, 320 165"/>
    <path class="line" d="M620 165 C640 165, 640 165, 660 165"/>
    <path class="line" d="M920 165 C940 165, 940 165, 960 165"/>

    <!-- KPI footer -->
    <rect x="40" y="288" width="1040" height="36" rx="14" fill="rgba(15,23,42,0.78)" stroke="rgba(55,65,81,0.85)"/>
    <text class="sub" x="64" y="311">
      Phase I KPIs: ≥70% faster turnaround · ≥90% reproducibility across reruns · ≥80% hypothesis usefulness (pilot rubric)
    </text>
  </svg>

  <div class="mini" style="margin-top:10px;">
    Tip: This figure is vector-based (SVG) so it prints cleanly into PDF and scales well on mobile.
  </div>
</section>
  
  <div class="grid">
    <div class="card">
      <h2>1) Phase I system workflow (end-to-end)</h2>
      <ul>
        <li><strong>Input:</strong> FASTQ / FCS (or public accession IDs) + minimal metadata template.</li>
        <li><strong>Automated pipelines:</strong> RNA-Seq (QC → alignment/quant → DEG → GSEA/GSVA) and flow cytometry preprocessing (QC → transforms → batch normalization → automated gating/summary).</li>
        <li><strong>Evidence-aware LLM layer:</strong> reads results, pulls supporting biology from PubMed + curated knowledge, then generates structured interpretation.</li>
        <li><strong>Hypothesis Generator:</strong> outputs ranked hypotheses + concrete follow-up experiments; each item includes traceable citations and “why this hypothesis” rationale.</li>
        <li><strong>Output:</strong> exportable HTML/PDF report (methods + figures + key findings + hypotheses + recommended experiments).</li>
      </ul>

      <div class="pill-row">
        <span class="pill">Reproducible configs</span>
        <span class="pill">Versioned outputs</span>
        <span class="pill">Audit trail</span>
        <span class="pill">HTML/PDF export</span>
      </div>
    </div>

    <div class="card">
      <h2>2) Validation datasets & study design</h2>
      <ul>
        <li><strong>Public-only evaluation:</strong> GEO/SRA for RNA-Seq, FlowRepository for flow cytometry (no restricted cohort data in Phase I).</li>
        <li><strong>Replicates & reruns:</strong> each dataset processed across multiple reruns to quantify reproducibility and stability.</li>
        <li><strong>Ground-truth anchors:</strong> compare recovered signals to known published contrasts (DE genes, pathways, canonical immune signatures).</li>
        <li><strong>Usability pilot:</strong> 2–3 partner reviewers (PI/analyst) score report clarity and hypothesis usefulness using a short rubric.</li>
      </ul>

      <div class="callout">
        <strong>Selection rule:</strong> choose ≥3 datasets spanning disease area and assay variability (different platforms / panels) to stress-test robustness.
      </div>
    </div>
  </div>

  <div class="row">
    <div class="card">
      <h2>3) Phase I success metrics (KPIs) & deliverables</h2>
      <ul>
        <li><strong>KPI-1: Turnaround time</strong> — target ≥70% reduction vs. manual analysis baselines (time-to-report).</li>
        <li><strong>KPI-2: Reproducibility</strong> — target ≥90% reproducibility across reruns (config-locked outputs, stable summary statistics).</li>
        <li><strong>KPI-3: Hypothesis usefulness</strong> — target ≥80% “useful/actionable” ratings from pilot rubric.</li>
        <li><strong>D1:</strong> hardened end-to-end pipelines on ≥3 public datasets (RNA-Seq + flow).</li>
        <li><strong>D2:</strong> traceable Hypothesis Generator with ranked hypotheses + experiment suggestions + PubMed citations.</li>
        <li><strong>D3:</strong> reviewer-ready HTML/PDF reports generated in &lt;24 hours from raw inputs.</li>
      </ul>

      <div class="mini">
        Note: KPI thresholds are adjustable to solicitation guidance; all Phase I validation uses public datasets to avoid IP/data-use conflicts.
      </div>
    </div>
  </div>
</main>

<footer>
  PromptGenix &middot; Phase I Approach &middot; Contact: <a href="mailto:dohoon.kim1@icloud.com">dohoon.kim1@icloud.com</a>
</footer>

</body>
</html>
